These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 31885495)

  • 1. Tumor Necrosis Factor (TNF) Receptor Expression Determines Keratinocyte Fate upon Stimulation with TNF-Like Weak Inducer of Apoptosis.
    Wang X; Cheng D; Hu G; Liang L; Tan F; Xiao T; Xiao S; Xia Y
    Mediators Inflamm; 2019; 2019():2945083. PubMed ID: 31885495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Necrosis Factor Receptor Mediates Fibroblast Growth Factor-Inducible 14 Signaling.
    Wang X; Xiao S; Xia Y
    Cell Physiol Biochem; 2017; 43(2):579-588. PubMed ID: 28934756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TWEAK/Fn14 interaction induces proliferation and migration in human airway smooth muscle cells via activating the NF-κB pathway.
    Zhu C; Zhang L; Liu Z; Li C; Bai Y
    J Cell Biochem; 2018 Apr; 119(4):3528-3536. PubMed ID: 29143982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-like weak inducer of apoptosis induces inflammation in Graves' orbital fibroblasts.
    Lee SJ; Kim J; Ko J; Lee EJ; Koh HJ; Yoon JS
    PLoS One; 2018; 13(12):e0209583. PubMed ID: 30576385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation.
    Cheng H; Xu M; Liu X; Zou X; Zhan N; Xia Y
    Exp Dermatol; 2016 Jan; 25(1):32-7. PubMed ID: 26264384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental atopic dermatitis is dependent on the TWEAK/Fn14 signaling pathway.
    Liu Q; Wang H; Wang X; Lu M; Tan X; Peng L; Tan F; Xiao T; Xiao S; Xia Y
    Clin Exp Immunol; 2020 Jan; 199(1):56-67. PubMed ID: 31515807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV Type 16 Infection Switches Keratinocytes from Apoptotic to Proliferative Fate under TWEAK/Fn14 Interaction.
    Cheng H; Zhan N; Ding D; Liu X; Zou X; Li K; Xia Y
    J Invest Dermatol; 2015 Oct; 135(10):2427-2436. PubMed ID: 26016896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWEAK inhibits TRAF2-mediated CD40 signaling by destabilization of CD40 signaling complexes.
    Salzmann S; Lang I; Rosenthal A; Schäfer V; Weisenberger D; Carmona Arana JA; Trebing J; Siegmund D; Neumann M; Wajant H
    J Immunol; 2013 Sep; 191(5):2308-18. PubMed ID: 23918987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha.
    Vince JE; Chau D; Callus B; Wong WW; Hawkins CJ; Schneider P; McKinlay M; Benetatos CA; Condon SM; Chunduru SK; Yeoh G; Brink R; Vaux DL; Silke J
    J Cell Biol; 2008 Jul; 182(1):171-84. PubMed ID: 18606850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TWEAK/Fn14 Activation Participates in Ro52-Mediated Photosensitization in Cutaneous Lupus Erythematosus.
    Liu Y; Xu M; Min X; Wu K; Zhang T; Li K; Xiao S; Xia Y
    Front Immunol; 2017; 8():651. PubMed ID: 28620393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TNF-like weak inducer of the apoptosis/fibroblast growth factor-inducible molecule 14 axis mediates histamine and platelet-activating factor-induced subcutaneous vascular leakage and anaphylactic shock.
    Mendez-Barbero N; Yuste-Montalvo A; Nuñez-Borque E; Jensen BM; Gutiérrez-Muñoz C; Tome-Amat J; Garrido-Arandia M; Díaz-Perales A; Ballesteros-Martinez C; Laguna JJ; Beitia JM; Poulsen LK; Cuesta-Herranz J; Blanco-Colio LM; Esteban V
    J Allergy Clin Immunol; 2020 Feb; 145(2):583-596.e6. PubMed ID: 31679818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWEAK/Fn14 Activation Participates in Skin Inflammation.
    Liu Q; Xiao S; Xia Y
    Mediators Inflamm; 2017; 2017():6746870. PubMed ID: 29038621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fn14 and TNFR2 as regulators of cytotoxic TNFR1 signaling.
    Siegmund D; Zaitseva O; Wajant H
    Front Cell Dev Biol; 2023; 11():1267837. PubMed ID: 38020877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8.
    Ikner A; Ashkenazi A
    J Biol Chem; 2011 Jun; 286(24):21546-54. PubMed ID: 21525013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14).
    Fick A; Lang I; Schäfer V; Seher A; Trebing J; Weisenberger D; Wajant H
    J Biol Chem; 2012 Jan; 287(1):484-495. PubMed ID: 22081603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of RANTES by TWEAK/Fn14 interaction in human keratinocytes.
    Jin L; Nakao A; Nakayama M; Yamaguchi N; Kojima Y; Nakano N; Tsuboi R; Okumura K; Yagita H; Ogawa H
    J Invest Dermatol; 2004 May; 122(5):1175-9. PubMed ID: 15140220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.
    Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W
    PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fn14 deficiency ameliorates psoriasis-like skin disease in a murine model.
    Peng L; Li Q; Wang H; Wu J; Li C; Liu Y; Liu J; Xia L; Xia Y
    Cell Death Dis; 2018 Jul; 9(8):801. PubMed ID: 30038329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWEAK/Fn14 Is Overexpressed in Crohn's Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune Pathways.
    Di Martino L; Osme A; Kossak-Gupta S; Pizarro TT; Cominelli F
    Cell Mol Gastroenterol Hepatol; 2019; 8(3):427-446. PubMed ID: 31181286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential fate decision landscape of the TWEAK/Fn14 axis on stem and progenitor cells: a systematic review.
    Wang S; Li L; Cook C; Zhang Y; Xia Y; Liu Y
    Stem Cell Res Ther; 2022 Jun; 13(1):270. PubMed ID: 35729659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.